Does DULAGLUTIDE Cause Basal cell carcinoma? 7 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Basal cell carcinoma have been filed in association with DULAGLUTIDE (Trulicity). This represents 0.0% of all adverse event reports for DULAGLUTIDE.
7
Reports of Basal cell carcinoma with DULAGLUTIDE
0.0%
of all DULAGLUTIDE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Basal cell carcinoma From DULAGLUTIDE?
Of the 7 reports, 2 (28.6%) required hospitalization, and 1 (14.3%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DULAGLUTIDE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does DULAGLUTIDE Cause?
Injection site pain (9,474)
Nausea (9,137)
Blood glucose increased (9,119)
Incorrect dose administered (5,207)
Diarrhoea (5,036)
Vomiting (4,880)
Inappropriate schedule of product administration (3,606)
Extra dose administered (3,047)
Injection site haemorrhage (3,028)
Weight decreased (3,000)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which DULAGLUTIDE Alternatives Have Lower Basal cell carcinoma Risk?
DULAGLUTIDE vs DULERA
DULAGLUTIDE vs DULOXETINE
DULAGLUTIDE vs DUPILUMAB
DULAGLUTIDE vs DURAGESIC
DULAGLUTIDE vs DUROGESIC